ADIPOQ and Insulin resistance: In particular, we observed decreased adiponectin and increased PAI-1 levels in the TBI and ABM groups (Figure 6, A and B), which could explain their emerging phenotype of insulin resistance (Figure 1, F and G) (49, 50).